Go to deals
Healthcare

Thubilux Pharma SpA has received a structured loan of US$2.7 million from a leading Italian bank

Tubilux Pharma SpA has successfully raised funds through a structured loan from Cassa Depositi e Prestiti SpA and Banca Intesa San Paolo SpA to support an investment plan for a new production facility which has all the FDA requirements to enter the USA market.

Tubilux Pharma is a leading, privately-held ophthalmic and pharmaceuticals company that develops and markets a range of proprietary, over-the-counter, and branded generic products, with distribution in approximately 30 countries. The firm's customers are large multinational pharmaceutical companies that outsource their production of ophthalmic products to specialized manufactures through medium-term supply contracts (3-5 years).

Oaklins' team in Italy advised Thubilux Pharma SpA in the structuring, negotiation and closing of a long-term debt financing from a leading Italian bank, backed by Cassa Depositi e Prestiti.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Federico  Cappa

Federico Cappa

Partner

Milan, Italy
Oaklins Italy
 Marie Gabriella  Sestini

Marie Gabriella Sestini

Associate

Turin, Italy
Oaklins Italy

Related deals

Ashtrom Group Ltd. has issued bonds to refinance the company
Real Estate

Ashtrom Group Ltd. has issued bonds to refinance the company

Ashtrom Group Ltd. has raised funds to refinance the company for further development.

Learn more
Azrieli Group Ltd. has raised capital through a bond placement
Real Estate

Azrieli Group Ltd. has raised capital through a bond placement

Azrieli Group Ltd. has completed a fundraising to refinance and develop the company.

Learn more
REIT 1 Ltd. has raised capital through a bond placement
Real Estate

REIT 1 Ltd. has raised capital through a bond placement

REIT 1 Ltd. has completed a fundraising to refinance and develop the company.

Learn more